We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

Guggenheim just gave Elevance Health a shiny new Buy rating and a bold $518 price target, despite the current $430.90 tag.

Shares of Elevance Health Inc. ELV rallied 1.11% to $435.68 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 9.52% to ...

A Relative Strength Rating upgrade for Elevance Health shows improving technical performance. Will it continue?

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $477.08, along with a high estimate of $512.00 and a low estimate of $405.40. Marking an ...

Mizuho raised the firm’s price target on Elevance Health (ELV) to $505 from $455 and keeps an Outperform rating on the shares. The firm ...

Guggenheim initiated coverage of Elevance Health (ELV) with a Buy rating and $518 price target The firm launched coverage on 11 healthcare ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ...

Equities researchers at Wolfe Research issued their FY2029 earnings per share (EPS) estimates for Elevance Health in a note issued to investors on Monday, March 31st. Wolfe Research analyst J. Lake ...